ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here. The ClearBridge Mid Cap Growth Strategy underperformed the Russell Midcap Growth Index during the third quarter. On an absolute basis, the Strategy had losses across eight of the 10 sectors […]

WAYNE, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list.

According to Market Study Report, Medical Corrugated Tubing Market provides a comprehensive analysis of the Medical Corrugated Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in

WAYNE, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34 th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET).

Teleflex Inc., a provider of medical technologies for critical care and surgery, has expanded the recall of various Gibeck Iso-Gard Filter products worldwide, the U.S. Food and Drug Administration said. The Gibeck Iso-Gard Filter, a bacterial and viral filter, is intended for connection to respiratory equipment in intensive care units and operating theatres.

WAYNE, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of affected lots of the below-referenced Gibeck Iso-Gard Filter products. The Gibeck Iso-Gard Filter is a bacterial and viral filter, intended for connection to respiratory equipment in intensive care units

Related Stocks: TFX , NFLX , BX , CDNS , TER ,

U.S. health regulators on Tuesday classified the recall of Teleflex Inc.’s Iso-Gard filter S, a medical device to protect patients from potential airborne contaminants, as most serious, saying its use could lead to injuries or death. The company recalled some models of the filter in August, after receiving reports of it splitting and getting detached […]

The FDA announced Tuesday that medical device maker Teleflex Incorporated (TFX) is recalling more than 2.7M of its Iso-Gard Filter S filters in the U.S

Teleflex Incorporated with ticker code (TFX) now have 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 370 and 215 with a mean TP of 256.15. Now with the previous closing price of 211 this now indicates there is a potential upside of 21.4%. There is a 50 day moving average of 214.55 and the 200 day MA is 275.79. The company has a market cap of $10,044m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $12,193m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

https://www.investing.com/news/pro/teleflex-pt-lowered-to-280-at-stephens-432SI-2925152

Related Stocks: DXCM , TFX , ABT , FSLR , VZ ,

Teleflex, Inc. (NYSE:NYSE:TFX) Q3 2022 Earnings Conference Call October 27, 2022 08:00 ET Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy…

WASHINGTON (dpa-AFX) - Specialty medical devices provider Teleflex Incorporated (TFX) Thursday reported lower profit in the third quarter, impacted by decline in revenue. The company also cut its …

Teleflex press release (TFX): Q3 Non-GAAP EPS of $3.27 beats by $0.16.Revenue of $686.8M (-1.9% Y/Y) misses by $4.72M.FY2022 revenue growth outlook is now expected to be (0.75)%…

WAYNE, Pa., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 25, 2022.

Teleflex (TFX) is scheduled to announce Q3 earnings results on Thursday, October 27th, before market open.The consensus EPS Estimate is $3.10 (-11.7% Y/Y) and the consensus Revenue Estimate…

Teleflex’s return on capital remains a standout and is a key feature to keep an eye on looking ahead. Find out why we are more constructive on TFX stock.

WAYNE, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, October 27, 2022. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed

Teleflex Incorporated found using ticker (TFX) have now 10 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 370 and 241 with a mean TP of 282.3. Given that the stocks previous close was at 199.43 this indicates there is a potential upside of 41.6%. There is a 50 day moving average of 230.08 while the 200 day moving average is 285.56. The company has a market cap of $9,110m. Visit the company website at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $12,895m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

(RTTNews) - Teleflex Inc. (TFX), a provider of specialty medical devices, said on Tuesday that it has released a new Arrow Pressure Injectable Midline portfolio in the U.S. and Canada. The enhancements in the new Arrow Midline Catheters are designed to help alleviate line identification confusion. The Arrowg+ard Blue Advance Midline with…

Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) releases their new Arrow Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance Midline with antimicrobial and antithrombogenic

Teleflex Incorporated with ticker code (TFX) have now 10 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 370 and 241 calculating the mean target price we have 282.3. Given that the stocks previous close was at 211.88 this is indicating there is a potential upside of 33.2%. The 50 day moving average now sits at 240.83 and the 200 day MA is 291.37. The company has a market cap of $9,732m. Visit the company website at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $12,966m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.